NCI scientists have crafted a novel approach to analyzing tumors that they say has the potential to bring precision cancer medicine to more patients. The new approach is based on analyzing gene expression in patients’ tumors. Gene expression is...
Read More »Study highlighting RNA role presented at recent ASCO meeting
An Ashion study poster presented May 29-31 at the 2020 annual meeting of the American Society for Clinical Oncology (ASCO) details the importance of using RNA as part of the analysis to give cancer...
Read More »The White House launches initiative in crowdsourcing rich RNA sequencing data
“This is good news in the fight against cancer. With the launch of this new national resource, anyone can freely access raw genomic and clinical data for 12,000 patients – with more records to follow. Increasing the pool of researchers ...
Read More »Featured RNA-Seq Job – Bioinformatics Analyst IV 613590 (NCI)
Leidos (Frederick, MD) COMPANY INFORMATION Leidos Biomedical Research, Inc., a wholly owned subsidiary of Leidos, operates the Frederick National Laboratory for Cancer Research, sponsored by the National Cancer Institute. Our focus is on basic and applied science in cancer and ...
Read More »NCI, TGEN and Dell collaborate on RNA-Seq Database
PHOENIX, Ariz. – Sept. 10, 2014 – Dell, Terascala and the Translational Genomics Research Institute (TGen) are installing state-of-the-art computing and programing specialized for human genome investigations at the National Cancer Institute (NCI). As part of a formal collaboration, Dell ...
Read More »The National Cancer Institute (NCI), Center for Cancer Research to purchase a NextSeq 500 Sequencer for ongoing RNA-Seq Studies
The Staudt laboratory at NCI performs a number of different genomics methodologies to discover oncogenic mechanisms in lymphoma, all of which require high-throughput DNA sequencing. Specifically, the laboratory developed loss-of-function genetic screens to discover new molecular targets in cancer using ...
Read More »